Chapter 1 HAI
Chapter 1 HAI
Urinary
Catheter
111111~'1,lililll~
foblo : Indications for urinary c:ithoteris:itlon
Haematuria
H
Obstructed
0
u Urologic surgery
Input/output monitoring
I
Not for resuscitation/end
N of life care: comfort
Immobility due to physical
I restraints
3. Woun ds/Bu rns Clostr idium (rnay lead to tetanu s and gas
gangre ne) Colifo rm bacilli
P-hern olytic strepto cocci Proteus species
P.aeruginosa Staph.aureus(coag. +ve)
Strep.fecalis
Entero bacter
4. Bacter ernia, Septic emia P.. aeruginosa S.typhimurium
• Age: Neonates & elderly persons of extreme ages are at greater risk of acquiring hospital
infections because of their longer stay and with inefficien t immunit y.
• Susceptib ility: Hospitali zed patients with pre-exist ing diseases like diabetes,
immunos uppressio n etc. are high risk groups and more susceptib le to infection s.
• Infected patients: Commun ity acquired or a non-hosp ital infection with which the
patient enters the hospital is due to pathogen ic microorg anisms. From these patients
there is risk of spread of infections from their close contacts to susceptib le patients and
attending staff.
• Hospital environment: The hospital environm ent is heavily laden with a variety of
pathogen s. Unhygien ic hospital environm ents can lead to transmis sion of diseases easily.
• If the hospital infection control policies are not accuratel y followed , spread of disease
could occur through food, water, personne l's handling patients etc.
• Surgical and diagnost ic procedures: The natural defense mechani sms of the body
surface may be bypassed by injury or by a diagnosti c of therapeu tic intervent ion like
usage of urethral or intraveno us catheters , endoscop ic tube t
sec.
• Drug resistance: The occurren~ e of drug resistant organism s like Colifor:rns an_d
Staphylococcus aureus that sometime s show increased virulence or transmiss ibility 15
usually hospital acquired .
• Transfusion: Blood, blood products or intraveno us fl ·a
transmit infections , if not properly screened . u1 s used for trans fusion can
p
.
ial or Hos pita l Acq uire d Intiect,a
Nosocom
.... ~-.-,r,, . r. . . n
.....,.,,, ...,.,
:,.,• - .~ '" - - - • j
• ,._. :
V. SOURCES OF HAis:
·
, pat hog emc
A. Endogenous sources·· Here tlle pat ·ien ts own normal flora (which are not d
• cho . n or disease. These path oge ns are calle
tmd er nor mal condition s) cause mfe
oge nic only whe n there is underlying disease & suc h
~ opp~rtunis~ic' as they bec ome path
o-infection.
infection as opportunistic infection or aut
B. Exogenous sources:
son nel
Patients & staff: HA is ma y be acquire
d by contact with pat ien t or hospital per
1.
carriers.
suffering from infection or asymptomatic
2. Environmental sources: These incl
ude:
wit h
be acquired indirectly by coming in contact
a. Inanimate objects (fomites): HA is may ,
h as sanitary installation (bed pan , urin als)
con tam ina ted equ ipm ents , materials suc
tabl e, blan ket, med ical equ ipm ent (end oscopes, catheters, needles, spa tula &
lights,
oth er inst rum ent s), floor, food & water.
flora of
b. Hospital air: Hos pita l air harbors
Gram positive cocci derived from bod y
stant bacteria which are often pathogenic.
hos pita l pop ula tion & also other dru g resi
pop ula tion of thes e bac teri a in hos pital air increases wit h overcrowding in
The
hospitals.
& bod y
c. Surfaces: Surfaces con tam inat ed
by patient's secretions, excretion, blood
fluids ma y also act as source of HAis.
6 4!tl·[email protected]@ ;
1
iv. Chest X-ray may be done when pneumonia is suspected to look for the presence of white
blood cells and other inflammato ry substances in lung tissue.
v. Laboratory tests including;
• Complete blood count to look for an increase in white blood cells .
- Urine analysis (urinalysis) to look for white cells or evidence of blood in the urinary
tract.
• Cultures of the infected area, blood, sputum, urine, or other body fluids or tissue to
find the causative organism.
• Bacterial infections:_ !he isolated organism is tested for sen sitivity to a range of
antibiotics. While waiting for thes~ t~s~ results, treatment m ay b egin w ith common bro~d
spectrum antibiotics such as p~nicillm, cephalospo rins, tetracycline s or erythromycin-
Since bacteria are becoming resistant to these standard antibiotic treatments; therefore,
more specific antibiotics must be used. Two such antibiotics that have been found
J
\filb·iJ.Mfoil·iihl4£ . .
7
effective against ..
resistant b
bacteria are develo . acteria are vanco .
F ping · resistance t th mycm
ese a r b · . and imipenem' a1th ough some
0
• ungal infections· A t"fu n 1 iohcs as well.
• · n i ng 1
itraconazole, and flu a agents like amphotericin B, nystat1·n,
. conazole are used. ketoconazole,
• . drugs that 1
Viral infection·. A n t·iviral
acyclovir, ganciclovir, foscarnet, ands ow the _growth or reproduction of viruses, such as
amantadme have been used
IX. PREVENTION OF HAis .
Prevention involves:
i. Appropriate Catheter use
n. Proper Techniques of Urinary Catheter Insertion
... p h . es of Urinary Catheter Maintenance
111. roper tee niqu
IT] ~-
~ A Text Book of Infection Control &
.
sa,ety
1
• ~nsur: that only trained personnel who know the correct technique of aseptic catheter
msertion and maintenanc e are given this responsibil ity.
♦ Use. sterile gloves: drape, spon
ges and an appropnate· •
antiseptic • or sterile
• solution
· for
penurethra l clearung and a single-use packet of 1 b · · 11y f or insertion.
u ncan t Je · ·
♦ Properly secure indwelling c th t
. a e ers a ft er msertion
· · to prevent movement and urethral
tractions.
♦ Unless otherwise clinically indicated
. . . , consi·der usmg
·
smallest bore catheter poss1·bl e,
consistent with good drainage to minimize bladde k d
r nee an ure thral trauma.
♦ If intermitten t catheter is used, perform it at regular · t
. . . m erva1s to prevent bl a d d er over-
distens10ns. Use a portable ultrasound device to access ·
. . urme vo1ume .m p atien
. t as
so , t0
reduce unnecessary catheter insertions.
L
I
I I
I I
I
I
''
' --. --------
a Ur in ar y
nd Hy gi en e fo cu s on ca rin g fo r a pa tie nt wi th
fo r Ha
Fig. 1.3 Th e 5 M om en ts Ca th ete r
INTENANCE
ER TE CH NI QU ES OF UR IN AR Y CATHETER MA
OP ge
PR
e Ur in ar y Ca th ete r, M ai nt ai n A Cl os ed Dr ai na
A. Fo llo wing As ep tic
In se rti on O f Th
an d
Sy ste m
cti on or lea ka ge oc cu rs, rep lac e the ca th ete r
♦ If br ea k in as ep tic
tec hn iq ue , di sc on ne
t.
m us in g as ep tic tec hn iq ue an d ste ril e eq ui pm en
co lle cti ng sy ste ng jun cti on s.
ou ld be pr ec on ne cte d wi th se ale d ca th ete r tu bi
♦ Ca th ete r sy ste m
sh
te d Ur in e Fl ow
B. M ain ta in Un ob str uc
kin g.
th e ca th ete r an d co lle cti ng tu be fre e fro m kin the
• Ke ep
el of bl ad de r at all tim es . Do no t re st the ba g on
g be lo w th e lev
• Ke ep th e bl ad de r ba
floor.
ba g reg ul arl y.
• Em pt y th e co lle cti ng es an d g ow n as ap prop riate,
durin g
di ng th e us e of gl ov
tio ns , in clu
C. Us e sta nd ar d pr ec au
y m an ip ul at io n of ca th ete r or co lle ct in g sy ste m. an d
an
ut i is to av oi d in se rti on of un ne ce ss ar y ca th ete rs
pr ev en tio n of ca
The be st str ate gy fo r th e ry .
ov e ca th ete rs on ce th ey ar e no lo ng er ne ce ssa
to rem
~
iMl·liMl=t#li@Mii;.f.■friw .
1. Sheath/condom catheter
2. Suprapubic catheterization
3. lntermitted catheterization
5. Bedside commode/urinal
to:-
• Dressing change frequency
• Catheter replacement
• Antisepsis of injection port
• Catheter selection
Prophylactic antimicrobials
•
• Education BSI
Female gender has lower incidence of CLA .
•
STRATEGIES TO PREVENT CLABSI
REPLACEMENT OF DEVICES
♦ There is no need to replace per·ip h era1 catheters frequently (can be done only in the case
of children).
PERFORMANACE IMPROVEMENT
• Use hospital-specific or collaborative based performance improvement initiatives in
which multifaceted strategies are bundled together to improve compliance with evidence
based recommended practices.
HOB at 30-459
r I
••
••
Fig. 1.5 Elevation of Head of Bed in Ventricul ar Bundle Approach
SURVEILLANCE OF HAis
ii. H os pi ta l en vi ro
nm en t.
es .
iii. St er ili za tio n &
di si nf ec tio n pr oc ed ur
th og en .
ic ro bi al se ns iti vi ty pa tte rn of pr ev al en t pa
iv. A nt im
og en s.
re si st an ce am on g pa th
v. Em er ge nc e of dr ug og en s sh ow no re sis ta
nc e.
ts ag ai ns t w hi ch pa th
tim ic ro bi al ag en
vi. Use of di ff er en t an nt ro l Te am
or ke rs , H os pi ta l A cq ui re d Infection Co
ve a te am of w ro l H A is.
The HAIC sh ou ld ha bi lit y fo r th e po lic y ad op te d to co nt
da y re sp on si
(HAICT) to ta ke da y to
es .
. .
1. T he m te ns iv e ca re •t (ICU) te am s u
n d er st an d th e im
reli es o n a cu lt ur u m p o rt an ce o f p ro
e of sa fe ty an d ev v id in g high-qua
id en ce -b as ed ch. . . lity
ru ca l p ra ct ic es to h el p .
2.
T he su bc la vi an an
d in te rn al ju gu la p re v en t infectionscarethc
rs ar e th e p re fe .
Fe m al e' s ur et hr al rr ed si te s fo r in
3. op en in g is cl os er fe ct io n- co nt ro l purp
to an u s w h er e U oses.
4. H os pi ta l ca n ap po in t ep id em T I ca u si n g b ac te ri a E .c ol
io lo gi st o r in fe i ar e found .
in fe ct io n co nt ro l ct io us d is ea se sp ec ia li
ph ys ic ia n. st , m ic ro bi ol og is
t to work"
5. P at ie nt sh ou ld b e in st ru ct
ed to sh o w er w
an d m or ni ng of it h so ap o r ch lo
th ei r su rg er y. rh ex id in e gl uc
on at e (CHG) at the
C lo
ms~
6. si ng su tu re s w it h T ri
cl os an co at ed an
ti .m ic ro bi al su tu
SSL re s is a si m p le
co nt ro l measure
to pmer
7. F em al e ge nd er
ha s lo w er in ci de
8. ReliaTect is a tr nc e of C L A B S I.
an sp ar en t, ch lo
ro he xi di ne gl uc
en ab le s w o u n d on at e C H G -e m
m on it or in g w it h b ed d ed po st -o pe
9. T he ho sp it al IC an in ta ct d re ss in ra ti on dressingth·1
C is ch ar ge d w it g fo r se v en d ay s.
h th e re sp on si bi
p rac ti.ce an d rm · 1 li ty fo r th e p la n n in g , ev
p em en ta ti·on , pr al ua ti on of eviden
in fe ct io n co nt ro io ri ti za ti on an d re so u rc e ce -ba5€(
l. al lo ca ti on of al
10 . C en tr al lm · l matters re latinu0 \l
e ar e al so ca ll ed
C en tr al V en o u s
m e d ic· ·
m es , flu1· ds, nu tr A cc es s D ev ic e
d
I a lo n g th in flex
m or e.
ie nt s o r b lo o d p
ro d u ct s o v er a . ible tube use to gil't
lo n g p er io d of ~~
ti m e, us ua ll y seve 1wee/\
11. C at he te r is ra
in se rt ed in th e ar
m , ne ck o r ch es
12. B ac te ra em
ia is th e pr es en ce t th ro u g h th e sk
in in to a la rg e ve
13 . S ep ti ca em ia
of ba ct er ia in b lo o d w it h in .
re fe rs to ci rc ul at o u t an y m ul ti pl
MP io n an d m ul ti pl ic at io n.
• re va le nc e al ic at io n of b ac te
so re fe rs to a pr ri a in th e b lo o d .
ev al en ce ra te is . n,,h 0
ha ve pa rt ic ul ar th e p ro p o rt io n
in a pop ~
di se as e ov er a sp of th e pe rs on s
15. In ci de nc e ra
te f ec if ie d p er io d o
t
re er s O the ra te f ti m e.
at w h ic h n ew ev . e
en t oc cu rs o v er
a sp ec if ie d pe ri·od of tif!l .
Revie w
Questions
QUi~•j:j:j:j!J~i*i
1. CLA BSI stands for
2. CAUTI stands for
DVT stand s for
4. MRSA stands for
s. · b ia
Closing sutures with Triclosa11-coate d an t·1m1cro ·
· a simple
. 1sutures 1s control measure to prevent
SSL
6. _____ is the causative organism of UTI.
7. Female gender has lower incidence of - - - -
8. _ __ _ is a transparent, chlorohexidi ne gluconate CHG-embed ded post-operatio n dressing that
enables wound monitoring with an intact dressing for seven days.
9. _ _ _ _ _ irrigation is preferred over antibiotic irrigation in the case of surgical site infection.
10. _ __ _ _ _ _ _is used for skin antisepsis
ANSWERS
1. central line-associat ed bloodstream infection 6. E.coli
2. catheter-asso ciated urinary tract infection 7. CLABSI
3. Deep Vein Thrombosis 8. ReliaTect
methicillin-r esistant Staphylococcus aureus 9. Antiseptic
4.
10. Chlorhexidin e
5. Triclosan-co ated
revention of CAUTI.
-- --
. ti
Q.1. Describe Bundle approach 111 ,e P case o f surg1•cal site infection.
. the
Q.2. Discuss 7S bundle approac h m
f HAI surveillance .
.
Q .3. Describe .
the rationale
· to prevent
CLABSI.°
Q .4. Elaborate various strategies